Phase II Trial of Single Agent ABT-888 With Post-Progression Therapy of ABT-888 in Combination With Carboplatin in Patients With Stage IV BRCA-Associated Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Veliparib (Primary) ; Carboplatin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jan 2018 Planned primary completion date changed from 31 Dec 2017 to 31 Dec 2018.
- 17 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 29 Mar 2017 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research.